Home/Filings/4/0001562180-23-000222
4//SEC Filing

PAKOLA STEVE 4

Accession 0001562180-23-000222

CIK 0001590877other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 4:06 PM ET

Size

11.6 KB

Accession

0001562180-23-000222

Insider Transaction Report

Form 4
Period: 2023-01-03
PAKOLA STEVE
Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2023-01-03$22.68/sh1,837$41,66315,313 total
  • Award

    Stock Options (Right to buy)

    2023-01-03+44,15544,155 total
    Exercise: $22.25Exp: 2033-01-03Common Stock (44,155 underlying)
  • Sale

    Common Stock

    2023-01-03$22.17/sh3,138$69,55912,175 total
  • Award

    Common Stock

    2023-01-03+90,588102,763 total
Footnotes (5)
  • [F1]Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021 and January 3, 2022. The number of shares withheld was determined on January 3, 2023 based on the closing price of the issuer's common stock on December 30, 2022.
  • [F2]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
  • [F3]This transaction was executed in multiple trades at prices ranging from $22.0000 to $22.3800. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F4]Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2024, January 1, 2025, January 1, 2026 and January 1, 2027 while the recipient provides continuous service to the Issuer.
  • [F5]25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 48 months following January 3, 2024 while the optionee provides continuous service to the Issuer.

Issuer

REGENXBIO Inc.

CIK 0001590877

Entity typeother

Related Parties

1
  • filerCIK 0001700659

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:06 PM ET
Size
11.6 KB